ClinicalTrials.govpublic full text
Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer
metastatic kidney carcinoma, recurrent renal cell carcinoma, stage iii renal cell cancer ajcc v7, stage iv renal cell cancer ajcc v7, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900149
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.